Jafron Biomedical Co Ltd
SZSE:300529
Relative Value
The Relative Value of one Jafron Biomedical Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 19.8 CNY, Jafron Biomedical Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Jafron Biomedical Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
J
|
Jafron Biomedical Co Ltd
SZSE:300529
|
15.8B CNY | 7.8 | 32.8 | 23.5 | 23.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
202.2B USD | 4.6 | 31 | 17.5 | 23.9 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
179.8B USD | 17.9 | 63 | 47.9 | 58.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
147.8B USD | 5.9 | 45.5 | 23 | 27.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
124.6B USD | 3.5 | 27 | 14.6 | 21.3 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
112.3B USD | 5.6 | 38.7 | 23 | 30.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.6B EUR | 2 | 22.5 | 12.3 | 17.4 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.8B USD | 12.3 | 49.9 | 35.7 | 39.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.6B USD | 2.3 | 28.7 | 11 | 18.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.7B USD | 8.2 | 46.3 | 25.8 | 28.2 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.2B USD | 1.9 | 18.3 | 12.9 | 15.7 |